The Chinese ophthalmic pharmaceutical market is forecast to grow from US$2.6 billion in 2019 to US$20.2 billion in 2030. Photo: Shutterstock
The Chinese ophthalmic pharmaceutical market is forecast to grow from US$2.6 billion in 2019 to US$20.2 billion in 2030. Photo: Shutterstock
Health in China
Business /  China Business

Hong Kong ophthalmic drugs pioneer sets its sights on cracking China’s US$20.2 billion eye disease treatment market

  • The Hong Kong-listed company aims to take a leading role in mainland China’s eye disease market as the country’s innovation ecosystem matures
  • According to China Insights Consultancy, the Chinese ophthalmic pharmaceutical market will grow from US$2.6 billion in 2019 to US$20.2 billion in 2030

Peggy Sito
Peggy Sito

Updated: 8:59am, 23 Dec, 2021

Why you can trust SCMP
The Chinese ophthalmic pharmaceutical market is forecast to grow from US$2.6 billion in 2019 to US$20.2 billion in 2030. Photo: Shutterstock
The Chinese ophthalmic pharmaceutical market is forecast to grow from US$2.6 billion in 2019 to US$20.2 billion in 2030. Photo: Shutterstock
READ FULL ARTICLE